Literature DB >> 16153607

Ferulic acid destabilizes preformed beta-amyloid fibrils in vitro.

Kenjiro Ono1, Mie Hirohata, Masahito Yamada.   

Abstract

Inhibition of the formation of beta-amyloid fibrils (fAbeta), as well as the destabilization of preformed fAbeta in the CNS, would be attractive therapeutic targets for the treatment of Alzheimer's disease (AD). We reported previously that curcumin (Cur) inhibits fAbeta formation from Abeta and destabilizes preformed fAbeta in vitro. Using fluorescence spectroscopic analysis with thioflavin T and electron microscopic studies, we examined the effects of ferulic acid (FA) on the formation, extension, and destabilization of fAbeta at pH 7.5 at 37 degrees C in vitro. We next compared the anti-amyloidogenic activities of FA with Cur, rifampicin, and tetracycline. Ferulic acid dose-dependently inhibited fAbeta formation from amyloid beta-peptide, as well as their extension. Moreover, it destabilized preformed fAbetas. The overall activity of the molecules examined was in the order of: Cur > FA > rifampicin = tetracycline. FA could be a key molecule for the development of therapeutics for AD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16153607     DOI: 10.1016/j.bbrc.2005.08.148

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  44 in total

Review 1.  A Review on Potential Footprints of Ferulic Acid for Treatment of Neurological Disorders.

Authors:  Surabhi Thapliyal; Tanveer Singh; Shailendra Handu; Manisha Bisht; Puja Kumari; Priyanka Arya; Pallavi Srivastava; Ravi Gandham
Journal:  Neurochem Res       Date:  2021-02-05       Impact factor: 3.996

2.  A novel, stable, aqueous glucagon formulation using ferulic acid as an excipient.

Authors:  Parkash A Bakhtiani; Nicholas Caputo; Jessica R Castle; Joseph El Youssef; Julie M Carroll; Larry L David; Charles T Roberts; W Kenneth Ward
Journal:  J Diabetes Sci Technol       Date:  2014-09-24

Review 3.  Nanotechnology to improve the Alzheimer's disease therapy with natural compounds.

Authors:  Maria João Ramalho; Stephanie Andrade; Joana Angélica Loureiro; Maria do Carmo Pereira
Journal:  Drug Deliv Transl Res       Date:  2020-04       Impact factor: 4.617

4.  Phenol red interacts with the protofibril-like oligomers of an amyloidogenic hexapeptide NFGAIL through both hydrophobic and aromatic contacts.

Authors:  Chun Wu; Hongxing Lei; Zhixiang Wang; Wei Zhang; Yong Duan
Journal:  Biophys J       Date:  2006-08-25       Impact factor: 4.033

5.  Phenolic compounds prevent amyloid β-protein oligomerization and synaptic dysfunction by site-specific binding.

Authors:  Kenjiro Ono; Lei Li; Yusaku Takamura; Yuji Yoshiike; Lijun Zhu; Fang Han; Xian Mao; Tokuhei Ikeda; Jun-ichi Takasaki; Hisao Nishijo; Akihiko Takashima; David B Teplow; Michael G Zagorski; Masahito Yamada
Journal:  J Biol Chem       Date:  2012-03-05       Impact factor: 5.157

6.  Glyceraldehyde-3-phosphate Dehydrogenase Aggregates Accelerate Amyloid-β Amyloidogenesis in Alzheimer Disease.

Authors:  Masanori Itakura; Hidemitsu Nakajima; Takeya Kubo; Yuko Semi; Satoshi Kume; Shusaku Higashida; Akihiro Kaneshige; Mitsuru Kuwamura; Naoki Harada; Akinori Kita; Yasu-Taka Azuma; Ryoichi Yamaji; Takashi Inui; Tadayoshi Takeuchi
Journal:  J Biol Chem       Date:  2015-09-10       Impact factor: 5.157

7.  Effect of phenolic compounds against Aβ aggregation and Aβ-induced toxicity in transgenic C. elegans.

Authors:  Seema Jagota; Jayakumar Rajadas
Journal:  Neurochem Res       Date:  2011-08-21       Impact factor: 3.996

8.  Combination therapy with octyl gallate and ferulic acid improves cognition and neurodegeneration in a transgenic mouse model of Alzheimer's disease.

Authors:  Takashi Mori; Naoki Koyama; Jun Tan; Tatsuya Segawa; Masahiro Maeda; Terrence Town
Journal:  J Biol Chem       Date:  2017-05-16       Impact factor: 5.157

9.  Discovery of amyloid-beta aggregation inhibitors using an engineered assay for intracellular protein folding and solubility.

Authors:  Li Ling Lee; HyungHo Ha; Young-Tae Chang; Matthew P DeLisa
Journal:  Protein Sci       Date:  2009-02       Impact factor: 6.725

10.  Phenolic compounds prevent Alzheimer's pathology through different effects on the amyloid-beta aggregation pathway.

Authors:  Tsuyoshi Hamaguchi; Kenjiro Ono; Atsushi Murase; Masahito Yamada
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.